Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001827506-25-000078
Filing Date
2025-06-06
Accepted
2025-06-06 16:33:54
Documents
1
Period of Report
2025-06-04

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1749242015.html 4  
1 FORM 4 wk-form4_1749242015.xml 4 3941
  Complete submission text file 0001827506-25-000078.txt   5481
Mailing Address 21823 30TH DR SE BOTHELL WA 98021
Business Address
SIEGALL CLAY B (Reporting) CIK: 0001167496 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40384 | Film No.: 251031244

Mailing Address 27 WEST 24TH STREET SUITE 702 NEW YORK NY 10010
Business Address 27 WEST 24TH STREET SUITE 702 NEW YORK NY 10010 646-481-9832
Tourmaline Bio, Inc. (Issuer) CIK: 0001827506 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)